Four interdisciplinary biomedical research projects have been selected for funding through the 2022 IBEST-OUHSC Cross-Campus Program, a co-funding mechanism created to facilitate the development of multidisciplinary teams of OU Norman and OU Health Sciences Center faculty to compete for external funding on significant cross-disciplinary healthcare research topics. The University of Oklahoma Institute for Biomedical Engineering, Science and Technology (IBEST) spans research and education activities in bioscience and biomedical engineering on the Norman and Oklahoma City campuses.
A pilot bedside-to-bench study, employing a pre-clinical localized ablative immunotherapy-based combination approach to modulate biomarkers of immunotherapy resistance identified in metastatic melanoma patients treated with immune checkpoint inhibitors
Lead by Prof. Abdul Rafeh Naqash, Internal Med/Oncology, OUHSC and Prof. Wei Chen, SBME, GCoE, OU Norman
Functional network alterations in medically intractable epilepsy
Led by Prof. Andrew Conner, Neurosurgery, OUHSC, Prof. James Scott, Psychiatry & Behavioral Sci, OUHSC, and Prof. Han Yuan, SBME, GCoE, OU Norman
Evaluation of anti-inflammatory immmunotherapy in a rodent model of intracerebral hemorrhage
Led by Prof. John Clegg, SBME, OU Norman and Prof. Andrew Bauer, Neurosurgery, OUHSC
Pilot research in cortical biomarkers for pain modulation
Led by Prof. Yuan Yang, SBME, GCoE, OU Norman and Prof. Desiree Azizoddin, TSET Health Promotion Research Center, OUHSC
“We especially appreciate the support from Prof. Ann West from Norman VPRP’s office and Prof. Darrin Akins from OUHSC VPR’s office in conducting external reviews to select these proposals,” said Lei Ding, IBEST director and the Lloyd and Joyce Austin Presidential Professor of Biomedical Engineering and Neuroscience in the Gallogly College of Engineering. “We also appreciate the support of the Center for Faculty Excellence at the Norman campus in proposal preparation and teaming efforts, as well as follow-up efforts to all applications teams in finding and securing future external funding.”
